M&A Deal Summary

Kymanox Acquires Neuma

On August 9, 2021, Kymanox acquired engineering company Neuma

Acquisition Highlights
  • This is Kymanox’s 1st transaction in the Engineering sector.
  • This is Kymanox’s 1st transaction in the United States.
  • This is Kymanox’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2021-08-09
Target Neuma
Sector Engineering
Buyer(s) Kymanox
Deal Type Add-on Acquisition
Advisor(s) Duane Morris (Legal)

Target

Neuma

King of Prussia, Pennsylvania, United States
Neuma is an engineering services firm, focused on rigorous design, development, and testing of novel medical technologies to rapidly evolve prototypes to products. Neuma leverages lean resourcing, intensive Design for Excellence (DFX) principles, and integrates system thinking into product development to transform early-stage technologies into commercial medical solutions. Neuma was founded in 2017 and is based in King of Prussia, Pennsylvania.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kymanox

Morrisville, North Carolina, United States
Category Company
Founded 2004
Sector Life Science
DESCRIPTION

Kymanox offers comprehensive engineering, development, and compliance support to clients who bring important gene and cell therapies, combination products, biopharmaceuticals, and medical devices to market. Kymanox leverages its team of project management professionals, engineers, scientists, and regulatory experts to facilitate the development and commercialization of products with optimized safety, quality, efficacy, and accessibility and with the overall goal of getting safe and effective therapies to patients faster. Kymanox was founded in 2004 and is based in Morrisville, North Carolina.

DEAL STATS #
Overall 1 of 3
Sector (Engineering) 1 of 1
Type (Add-on Acquisition) 1 of 3
State (Pennsylvania) 1 of 1
Country (United States) 1 of 2
Year (2021) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-02 Anteris medical

Holzkirchen, Germany

Anteris medical specializes in supporting the development and commercialization of combination products, medical devices, and in-vitro diagnostic products. Anteris medical was founded in 2014 and is based in Holzkirchen, Germany.

Buy -
Mergr

Product

Company

Legal